Stockholders’ Equity (Deficit) |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Equity [Abstract] | |
| Stockholders’ Equity (Deficit) | Stockholders’ Equity (Deficit) Stock Repurchase Program In March 2025, the Company’s Board of Directors (the “Board”) authorized a stock repurchase program to allow for the repurchase of up to $500,000 of shares of the Company’s common stock for the period from March 7, 2025, to March 6, 2027 (the “Stock Repurchase Program”). During the three months ended March 31, 2025, the Company repurchased and retired 8,268,937 shares of the Company’s common stock for an aggregate purchase price of $141,139, which equates to an average price of $17.07 per share. As of March 31, 2025, the Company has an aggregate of $358,861 authorized and remaining under the Stock Repurchase Program. Amounts reflected above are based on the trade date and differ from the condensed consolidated statements of cash flows which reflects stock repurchases based on the settlement date. The difference of $9,155 was accrued and recorded in “Accrued expenses and other current liabilities” in the condensed consolidated balance sheets as of March 31, 2025. The Company may repurchase shares of the Company’s common stock in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The amount and timing of any repurchases will depend on a number of factors including the price and availability of the Company's common stock, trading volume, and general market conditions.
|